Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
Harvard Business School
Daiichi Sankyo
Healthtrust
Fish and Richardson

Generated: July 18, 2019

DrugPatentWatch Database Preview

Patent: 9,867,806

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,867,806
Title:Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
Abstract: The present invention discloses compounds according to Formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, L, and the subscript m are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions, and methods of treatment using the same, for the treatment of cystic fibrosis by administering a compound of the invention.
Inventor(s): De Blieck; Ann (Mechelen, BE), De Munck; Tom Roger Lisette (Mechelen, BE), Joannesse; Caroline Martine Andre (Mechelen, BE), Kelgtermans; Hans (Mechelen, BE), Mammoliti; Oscar (Mechelen, BE), Menet; Christel Jeanne Marie (Mechelen, BE), Tricarico; Giovanni Alessandro (Mechelen, BE), Van der Plas; Steven Emiel (Mechelen, BE)
Assignee: Galapagos NV (Mechelen, BE)
Application Number:15/160,639
Patent Claims:see list of patent claims

Details for Patent 9,867,806

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech PULMOZYME dornase alfa VIAL 103532 001 1993-12-30 ➤ Try a Free Trial Galapagos NV (Mechelen, BE) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Baxter
Boehringer Ingelheim
Accenture
Express Scripts
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.